RxDoctor Payments Data

Yi Ding, MD

Anatomic Pathology & Clinical Pathology · Rochester, NYNPI 1679884274

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.3%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Cepheid at 30.7% of the total. Among anatomic pathology & clinical pathology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,525in general payments, 2019–2025

Across 17 payments — averaging $1030.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cepheid$5K
  • Life Technologies Corporation$5K
  • AstraZeneca$3K
  • Roche Diagnostics Corporation$2K
  • Bayer$2K
  • Stemline Therapeutics Inc.$41
  • plus $67 from 2 others
$77,620in research payments, 2019–2025

Across 3 payments — averaging $25,873 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cepheid$78K

What the payments were for

  • Consulting fees$7,31342%
  • Speaking & faculty fees$9,16052%
  • Travel & lodging$8785%
  • Food & beverage$1741%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,525 in reported general payments places this provider in the 95th percentile of 468 anatomic pathology & clinical pathology providers in New York.

See all anatomic pathology & clinical pathology providers in New York

Medicare billing

Part B allowed, 2024
$41,657
Medicare patients
880
Services billed
1,645

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →